A Phase IV Investigation of Sugammadex in Outpatient Urological Procedures
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine; Rocuronium bromide
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 19 Sep 2017 Planned End Date changed from 1 Nov 2019 to 1 Sep 2019.
- 19 Sep 2017 Planned primary completion date changed from 1 Nov 2019 to 1 Sep 2019.
- 19 Sep 2017 Status changed from not yet recruiting to recruiting.